Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Elbert, K. J."'
Autor:
Padilla, D., VerBerkmoes, J. L., Elbert, K. J., Sung, J. C., Hickey, A. J., Edwards, D. A., Garcia-Contreras, L., Telko, M., Muttil, P.
Novel treatments for multidrug-resistant tuberculosis (MDR-TB), extensively drug-resistant tuberculosis (XDR-TB), or latent TB are needed urgently. Recently, we reported the formulation and characterization of the nitroimidazo-oxazine PA-824 for effi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0d30e5f8f173091706d05d66ee11aa1
Autor:
VerBerkmoes, J. L., Sung, J. C., Hickey, A. J., Edwards, D. A., Peloquin, C. A., Elbert, K. J., Garcia-Contreras, L.
We formulated PA-824, a nitroimidazopyran with promise for the treatment of tuberculosis, for efficient aerosol delivery to the lungs in a dry powder porous particle form. The objectives of this study were to prepare and characterize a particulate fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::552cadb6736cd32cc5d09478302366ab
Autor:
Elbert KJ; Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany., Schäfer UF, Schäfers HJ, Kim KJ, Lee VH, Lehr CM
Publikováno v:
Pharmaceutical research [Pharm Res] 1999 May; Vol. 16 (5), pp. 601-8.
Autor:
Basu SK; Department of Pharmaceutical Sciences, University of Southern California, Los Angeles 90033, USA., Shen J, Elbert KJ, Okamoto CT, Lee VH, von Grafenstein H
Publikováno v:
Pharmaceutical research [Pharm Res] 1998 Feb; Vol. 15 (2), pp. 338-42.